Literature DB >> 29778523

Local Immunomodulation with Anti-inflammatory Cytokine-Encoding Lentivirus Enhances Functional Recovery after Spinal Cord Injury.

Jonghyuck Park1, Joseph T Decker1, Daniel J Margul2, Dominique R Smith1, Brian J Cummings3, Aileen J Anderson3, Lonnie D Shea4.   

Abstract

Trauma to the spinal cord and associated secondary inflammation can lead to permanent loss of sensory and motor function below the injury level, with the resulting environment serving as a barrier that limits regeneration. In this study, we investigate the localized expression of anti-inflammatory cytokines IL-10 and IL-4 via lentiviral transduction in multichannel bridges. Porous multichannel bridges provide physical guidance for axonal outgrowth with the cytokines hypothesized to modulate the neuroinflammatory microenvironment and enhance axonal regeneration. Gene expression analyses indicated that induced IL-10 and IL-4 expression decreased expression of pro-inflammatory genes and increased pro-regenerative genes relative to control. Moreover, these factors led to increased numbers of axons and myelination, with approximately 45% of axons myelinated and the number of oligodendrocyte myelinated axons significantly increased by 3- to 4-fold. Furthermore, the combination of a bridge with IL-10 and IL-4 expression improved locomotor function after injury to an average score of 6 relative to an average score of 3 for injury alone. Collectively, these studies highlight the potential for localized immunomodulation to decrease secondary inflammation and enhance regeneration that may have numerous applications.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  anti-inflammatory cytokines; immunoengineering; lentiviral gene delivery; multichannel bridge; spinal cord injury

Mesh:

Substances:

Year:  2018        PMID: 29778523      PMCID: PMC6037204          DOI: 10.1016/j.ymthe.2018.04.022

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  18 in total

Review 1.  It's All in the Delivery: Designing Hydrogels for Cell and Non-viral Gene Therapies.

Authors:  Richard L Youngblood; Norman F Truong; Tatiana Segura; Lonnie D Shea
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

Review 2.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

3.  Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model.

Authors:  Dominique R Smith; Courtney M Dumont; Jonghyuck Park; Andrew J Ciciriello; Amina Guo; Ravindra Tatineni; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2020-02-25       Impact factor: 3.845

4.  Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury.

Authors:  Jonghyuck Park; Yining Zhang; Eiji Saito; Steve J Gurczynski; Bethany B Moore; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

5.  Reducing inflammation through delivery of lentivirus encoding for anti-inflammatory cytokines attenuates neuropathic pain after spinal cord injury.

Authors:  Jonghyuck Park; Joseph T Decker; Dominique R Smith; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  J Control Release       Date:  2018-10-06       Impact factor: 9.776

6.  Regulation of adipose tissue inflammation and systemic metabolism in murine obesity by polymer implants loaded with lentiviral vectors encoding human interleukin-4.

Authors:  Richard Youngblood; Carmen G Flesher; Jennifer Delproposto; Nicki A Baker; Christopher K Neeley; Fanghua Li; Carey N Lumeng; Lonnie D Shea; Robert W O'Rourke
Journal:  Biotechnol Bioeng       Date:  2020-08-18       Impact factor: 4.530

7.  IL-10 lentivirus-laden hydrogel tubes increase spinal progenitor survival and neuronal differentiation after spinal cord injury.

Authors:  Andrew J Ciciriello; Dominique R Smith; Mary K Munsell; Sydney J Boyd; Lonnie D Shea; Courtney M Dumont
Journal:  Biotechnol Bioeng       Date:  2021-04-23       Impact factor: 4.395

8.  Exosomes-Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth.

Authors:  Lei Fan; Can Liu; Xiuxing Chen; Lei Zheng; Yan Zou; Huiquan Wen; Pengfei Guan; Fang Lu; Yian Luo; Guoxin Tan; Peng Yu; Dafu Chen; Chunlin Deng; Yongjian Sun; Lei Zhou; Chengyun Ning
Journal:  Adv Sci (Weinh)       Date:  2022-03-06       Impact factor: 17.521

9.  Lentiviral Interleukin-10 Gene Therapy Preserves Fine Motor Circuitry and Function After a Cervical Spinal Cord Injury in Male and Female Mice.

Authors:  Emily J Fu; Paras R Patel; Jessica Y Chen; Alexander J Hostetler; Hasan A Sawan; Kayla A Moss; Sarah E Hocevar; Aileen J Anderson; Cynthia A Chestek; Lonnie D Shea
Journal:  Neurotherapeutics       Date:  2020-10-13       Impact factor: 7.620

Review 10.  Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?

Authors:  Kufreobong E Inyang; Joseph K Folger; Geoffroy Laumet
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.